Remarkably, CACS was fully reversed in all the female mice treated with the combination of Ana and ActRIIB-Fc (Fig. 5g) without changes in lung mass, a surrogate for tumor burden (Fig. S5e). The gene discussed is ACVR2B; the disease is neoplasm.